⌘K

Home/Filings/4/0001404219-09-000035

4//SEC Filing

GENENTECH INC 4

Accession 0001404219-09-000035

CIK 0000318771operating

View on SEC.gov Company Profile

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 2:55 PM ET

Size

24.8 KB

Accession

0001404219-09-000035

Insider Transaction Report

Form 4

Period: 2009-03-26

GENENTECH INCDNA

SANDERS CHARLES A

Director

Transactions

Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−40,000→ 0 total
Exercise: $21.47From: 1999-11-30Exp: 2009-11-30→ Common Stock (40,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−8,000→ 0 total
Exercise: $32.84From: 2000-05-15Exp: 2010-05-15→ Common Stock (8,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−20,000→ 0 total
Exercise: $58.63From: 2005-04-14Exp: 2015-04-14→ Common Stock (20,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−15,000→ 0 total
Exercise: $80.40From: 2006-04-20Exp: 2016-04-20→ Common Stock (15,000 underlying)
Disposition to Issuer
Common Stock
2009-03-26$95.00/sh−2,000$190,000→ 0 total
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−5,000→ 0 total
Exercise: $18.60From: 2003-04-23Exp: 2013-04-23→ Common Stock (5,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−20,000→ 0 total
Exercise: $26.10From: 2001-05-10Exp: 2011-05-10→ Common Stock (20,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−39,800→ 0 total
Exercise: $54.39From: 2004-04-16Exp: 2014-04-16→ Common Stock (39,800 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−11,000→ 0 total
Exercise: $82.40From: 2007-10-20Exp: 2017-04-20→ Common Stock (11,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−15,000→ 0 total
Exercise: $74.06From: 2008-10-15Exp: 2018-04-15→ Common Stock (15,000 underlying)

Footnotes (4)

[F1]Disposed of pursuant to the Agreement and Plan of Merger between the issuer, Roche Holdings Inc. and Roche Investments USA dated March 12, 2009.
[F2]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
[F3]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
[F4]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

GENENTECH INC

CIK 0000318771

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000318771

Filing Metadata

Form type: 4
Filed: Mar 30, 8:00 PM ET
Accepted: Mar 31, 2:55 PM ET
Size: 24.8 KB

View on SEC.gov